Old Web
English
Sign In
Acemap
>
authorDetail
>
Christoph Reuter
Christoph Reuter
Hannover Medical School
Oncology
Internal medicine
Medicine
Prostate cancer
Docetaxel
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prognostic role of docetaxel-induced reduction of free testosterone serum levels in metastatic prostate cancer patients.
2021
Journal of Clinical Oncology
Paula Kappler
Stefan Brunotte
Philipp Ivanyi
Michael A. Morgan
Christoph Reuter
Show All
Source
Cite
Save
Citations (0)
Role of free testosterone serum levels during salvage chemotherapy with carboplatin plus weekly docetaxel in patients with docetaxel-refractory, metastatic castration-resistant prostate cancer (mCRPC).
2021
Journal of Clinical Oncology
Stefan Brunotte
Philipp Ivanyi
Paula Kappler
Michael A. Morgan
Christoph Reuter
Show All
Source
Cite
Save
Citations (0)
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives
2021
Hormone and Metabolic Research
Frederik A. Verburg
Holger Amthauer
Ina Binse
Ingo Brink
Andreas K. Buck
Andreas Darr
Christine Dierks
Christine Koch
Ute König
Michael C. Kreissl
Markus Luster
Christoph Reuter
Klemens Scheidhauer
Holger S. Willenberg
Andreas Zielke
Matthias Schott
Show All
Source
Cite
Save
Citations (3)
1